A Study of MG2512 Injection in Participants With Advanced Solid Tumors

NCT07348653 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

116

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: MG2512 Injection

Sponsor

Shanghai Mabgen Biopharmaceutical Technology Co., Ltd.